Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
31. Oktober 2024 08:00 ET
|
Mangoceuticals, Inc.
Dallas, Texas, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...
MangoRx Announces Formation of Strategy and Alternatives Committee
22. Oktober 2024 08:00 ET
|
Mangoceuticals, Inc.
Dallas, Texas, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness...
Sexual Enhancers Global Market Overview 2024
03. Oktober 2024 10:10 ET
|
Research and Markets
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The "Sexual Enhancers - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Sexual Enhancers is...
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
15. August 2024 09:25 ET
|
Mangoceuticals, Inc.
Dallas, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access
18. Juli 2024 16:05 ET
|
Mangoceuticals, Inc.
DALLAS, TEXAS, July 18, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company”), a company focused on developing, marketing, and selling a variety of men’s health...
MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts
16. Juli 2024 08:20 ET
|
Mangoceuticals, Inc.
DALLAS, TX, July 16, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and...
MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department
12. Juli 2024 13:30 ET
|
Mangoceuticals, Inc.
DALLAS, TEXAS, July 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets
11. Juli 2024 08:15 ET
|
Mangoceuticals, Inc.
DALLAS, TEXAS, July 11, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men’s health...
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
06. Juni 2024 08:30 ET
|
Mangoceuticals, Inc.
Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...
Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets
28. Mai 2024 08:30 ET
|
Mangoceuticals, Inc.
Dallas, Texas, May 28, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health...